Antineoplastic drug contamination and safe handling practices in Canadian healthcare centres: Results from the 2025 monitoring program

IntroductionOccupational exposure to antineoplastic drugs remains a significant concern for healthcare workers. Surface contamination is a key indicator of exposure risks and reflects the effectiveness of practices. This study aimed to describe contamination with 11 antineoplastic drugs on 12 surfaces in Canadian healthcare centres participating in the 2025 monitoring program and to examine practices implemented by these centres, including the potential influence of hazardous drug committees.MethodsEach centre sampled six standardized sites in oncology pharmacies and six in outpatient clinics. Ultra-performance liquid chromatography-tandem mass spectrometry quantified cyclophosphamide, docetaxel, doxorubicin, etoposide, 5-fluorouracil, gemcitabine, irinotecan, methotrexate, paclitaxel and vinorelbine. Inductively coupled plasma mass spectrometry quantified platinum-based drugs. The Kolmogorov-Smirnov test assessed differences in contamination, and chi-square tests compared practice implementation.ResultsA total of 127 centres participated. Overall, 35% (504/1 453) of surfaces were contaminated, most frequently cyclophosphamide (22%, 90<sup>th</sup> percentile 0.0052 ng/cm<sup>2</sup>) and gemcitabine (14%, 0.0017 ng/cm<sup>2</sup>). The most contaminated sites were the front grille inside the biological safety cabinet (70%) and the armrest of the treatment chair (67%). More than half of centres (67/122, 55%) reported having a hazardous drugs committee. Cyclophosphamide surface contamination differed by committee presence and meeting frequency (<i>p</i> = 0.034). Centres with a committee were more likely to implement certain handling practices, including cleaning vials before storage (<i>p</i> = 0.004).ConclusionsSurface contamination remains frequent but at low concentrations, with evidence of improvement over time. Multidisciplinary committees, continuous monitoring and broader staff engagement are essential to strengthen safety culture and reduce occupational exposure.

Authors

Institutions

Publication Details

Journal
Journal of Oncology Pharmacy Practice
Published
2026-01-27
DOI
https://doi.org/10.1177/10781552261416401
Primary Topic
Safe Handling of Antineoplastic Drugs
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Antineoplastic drug contamination and safe handling practices in Canadian healthcare centres: Results from the 2025 monitoring program

Ciprian Mihai Cirtiu, Marine Elluard, Nicolas Caron, Cynthia Tanguay et al.
Journal of Oncology Pharmacy Practice
Safe Handling of Antineoplastic Drugs
article

Antineoplastic drug contamination and safe handling practices in Canadian healthcare centres: Results from the 2025 monitoring program

Ciprian Mihai Cirtiu, Marine Elluard, Nicolas Caron, Cynthia Tanguay, Jean-François Bussières
article en

Abstract

IntroductionOccupational exposure to antineoplastic drugs remains a significant concern for healthcare workers. Surface contamination is a key indicator of exposure risks and reflects the effectiveness of practices. This study aimed to describe contamination with 11 antineoplastic drugs on 12 surfaces in Canadian healthcare centres participating in the 2025 monitoring program and to examine practices implemented by these centres, including the potential influence of hazardous drug committees.MethodsEach centre sampled six standardized sites in oncology pharmacies and six in outpatient clinics. Ultra-performance liquid chromatography-tandem mass spectrometry quantified cyclophosphamide, docetaxel, doxorubicin, etoposide, 5-fluorouracil, gemcitabine, irinotecan, methotrexate, paclitaxel and vinorelbine. Inductively coupled plasma mass spectrometry quantified platinum-based drugs. The Kolmogorov-Smirnov test assessed differences in contamination, and chi-square tests compared practice implementation.ResultsA total of 127 centres participated. Overall, 35% (504/1 453) of surfaces were contaminated, most frequently cyclophosphamide (22%, 90<sup>th</sup> percentile 0.0052 ng/cm<sup>2</sup>) and gemcitabine (14%, 0.0017 ng/cm<sup>2</sup>). The most contaminated sites were the front grille inside the biological safety cabinet (70%) and the armrest of the treatment chair (67%). More than half of centres (67/122, 55%) reported having a hazardous drugs committee. Cyclophosphamide surface contamination differed by committee presence and meeting frequency (<i>p</i> = 0.034). Centres with a committee were more likely to implement certain handling practices, including cleaning vials before storage (<i>p</i> = 0.004).ConclusionsSurface contamination remains frequent but at low concentrations, with evidence of improvement over time. Multidisciplinary committees, continuous monitoring and broader staff engagement are essential to strengthen safety culture and reduce occupational exposure.

Journal of Oncology Pharmacy Practice
Centre Hospitalier Universitaire Sainte-Justine (CA), Institut National de Santé Publique (GN), Université de Montréal (CA)
Openalex Percentile: Top 77%
Safe Handling of Antineoplastic Drugs
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.